Where's it on?
FDA · Drugs ·

Liraglutide Injection recall

Lupin Pharmaceuticals Inc. recalled Liraglutide Injection on May 27, 2026 because of presence of particulate matter: a white thread-like structure in the cartridge. It was sold nationwide.

Why it was recalled

Presence of particulate matter: a white thread-like structure in the cartridge

What's recalled

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.

Quantity: 217,621 pen injectors

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice